Q2 2025 · 13F-HR
Data Collective IV GP, LLCholdings as filed
Filed 2025-08-14 · accession 0001104659-25-078013
$129.9M
Reported value
5
Positions
2025-06-30
Period end
The Brief · Data Collective IV GP, LLC · Q2 2025
AI · grounded in 13F
Data Collective IV GP, LLC established five new positions to reach a total AUM of $129.9M. The fund's largest move was a $60.4M investment in Evolv Technologies Holdings, Inc. EVLV. Other new entries include Rocket Lab Corp RKLB at $38.7M and Recursion Pharmaceuticals, Inc. RXRX at $30.1M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 30049H102 | EVLV | Evolv Technologies Holdings, Inc. | $60.4M | 46.5% | 9,681,281 | Common | SOLE |
| 773121108 | RKLB | Rocket Lab Corp | $38.7M | 29.8% | 1,083,053 | Common | SOLE |
| 75629V104 | RXRX | Recursion Pharmaceuticals, Inc. | $30.1M | 23.1% | 5,941,120 | Common | SOLE |
| 60255C885 | BRD1EUR | Mind Medicine (MindMed) Inc. | $651,272 | 0.50% | 100,350 | Common | SOLE |
| G76279101 | ROIV | Roivant Sciences Ltd. | $43,671 | 0.03% | 3,875 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.